Report Cover

Global Measles Vaccine Sales Market Report 2021


The global Measles Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Measles Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
    Mumps Measles Rubella Vaccine, Live (MMR-II)
    Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

Segment by Application
    Children
    Adults

The Measles Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Measles Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
    GSK
    Sanofi-Pasteur
    Merck
    Novartis
    Pfizer
    Serum Institute of India
    China National Biotech Group
    Bavarian Nordic
    Emergent Biosolutions
    Medimmune
    Johnson & Johnson
    CSL Limited
1 Measles Vaccine Market Overview
    1.1 Measles Vaccine Product Scope
    1.2 Measles Vaccine Segment by Type
        1.2.1 Global Measles Vaccine Sales by Type (2016 & 2021 & 2027)
        1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
        1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
    1.3 Measles Vaccine Segment by Application
        1.3.1 Global Measles Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 Children
        1.3.3 Adults
    1.4 Measles Vaccine Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Measles Vaccine Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Measles Vaccine Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Measles Vaccine Price Trends (2016-2027)

2 Measles Vaccine Estimates and Forecasts by Region
    2.1 Global Measles Vaccine Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Measles Vaccine Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Measles Vaccine Sales Market Share by Region (2016-2021)
        2.2.2 Global Measles Vaccine Revenue Market Share by Region (2016-2021)
    2.3 Global Measles Vaccine Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Measles Vaccine Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Measles Vaccine Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Measles Vaccine Estimates and Projections (2016-2027)
        2.4.2 Europe Measles Vaccine Estimates and Projections (2016-2027)
        2.4.3 China Measles Vaccine Estimates and Projections (2016-2027)
        2.4.4 Japan Measles Vaccine Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Measles Vaccine Estimates and Projections (2016-2027)
        2.4.6 India Measles Vaccine Estimates and Projections (2016-2027)

3 Global Measles Vaccine Competition Landscape by Players
    3.1 Global Top Measles Vaccine Players by Sales (2016-2021)
    3.2 Global Top Measles Vaccine Players by Revenue (2016-2021)
    3.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2020)
    3.4 Global Measles Vaccine Average Price by Company (2016-2021)
    3.5 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Measles Vaccine Market Size by Type
    4.1 Global Measles Vaccine Historic Market Review by Type (2016-2021)
        4.1.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
        4.1.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
        4.1.3 Global Measles Vaccine Price by Type (2016-2021)
    4.2 Global Measles Vaccine Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Measles Vaccine Sales Forecast by Type (2022-2027)
        4.2.2 Global Measles Vaccine Revenue Forecast by Type (2022-2027)
        4.2.3 Global Measles Vaccine Price Forecast by Type (2022-2027)

5 Global Measles Vaccine Market Size by Application
    5.1 Global Measles Vaccine Historic Market Review by Application (2016-2021)
        5.1.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
        5.1.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
        5.1.3 Global Measles Vaccine Price by Application (2016-2021)
    5.2 Global Measles Vaccine Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Measles Vaccine Sales Forecast by Application (2022-2027)
        5.2.2 Global Measles Vaccine Revenue Forecast by Application (2022-2027)
        5.2.3 Global Measles Vaccine Price Forecast by Application (2022-2027)

6 North America Measles Vaccine Market Facts & Figures
    6.1 North America Measles Vaccine Sales by Company
        6.1.1 North America Measles Vaccine Sales by Company (2016-2021)
        6.1.2 North America Measles Vaccine Revenue by Company (2016-2021)
    6.2 North America Measles Vaccine Sales Breakdown by Type
        6.2.1 North America Measles Vaccine Sales Breakdown by Type (2016-2021)
        6.2.2 North America Measles Vaccine Sales Breakdown by Type (2022-2027)
    6.3 North America Measles Vaccine Sales Breakdown by Application
        6.3.1 North America Measles Vaccine Sales Breakdown by Application (2016-2021)
        6.3.2 North America Measles Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Measles Vaccine Market Facts & Figures
    7.1 Europe Measles Vaccine Sales by Company
        7.1.1 Europe Measles Vaccine Sales by Company (2016-2021)
        7.1.2 Europe Measles Vaccine Revenue by Company (2016-2021)
    7.2 Europe Measles Vaccine Sales Breakdown by Type
        7.2.1 Europe Measles Vaccine Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Measles Vaccine Sales Breakdown by Type (2022-2027)
    7.3 Europe Measles Vaccine Sales Breakdown by Application
        7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Measles Vaccine Market Facts & Figures
    8.1 China Measles Vaccine Sales by Company
        8.1.1 China Measles Vaccine Sales by Company (2016-2021)
        8.1.2 China Measles Vaccine Revenue by Company (2016-2021)
    8.2 China Measles Vaccine Sales Breakdown by Type
        8.2.1 China Measles Vaccine Sales Breakdown by Type (2016-2021)
        8.2.2 China Measles Vaccine Sales Breakdown by Type (2022-2027)
    8.3 China Measles Vaccine Sales Breakdown by Application
        8.3.1 China 155 Sales Breakdown by Application (2016-2021)
        8.3.2 China 155 Sales Breakdown by Application (2022-2027)

9 Japan Measles Vaccine Market Facts & Figures
    9.1 Japan Measles Vaccine Sales by Company
        9.1.1 Japan Measles Vaccine Sales by Company (2016-2021)
        9.1.2 Japan Measles Vaccine Revenue by Company (2016-2021)
    9.2 Japan Measles Vaccine Sales Breakdown by Type
        9.2.1 Japan Measles Vaccine Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Measles Vaccine Sales Breakdown by Type (2022-2027)
    9.3 Japan Measles Vaccine Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Measles Vaccine Market Facts & Figures
    10.1 Southeast Asia Measles Vaccine Sales by Company
        10.1.1 Southeast Asia Measles Vaccine Sales by Company (2016-2021)
        10.1.2 Southeast Asia Measles Vaccine Revenue by Company (2016-2021)
    10.2 Southeast Asia Measles Vaccine Sales Breakdown by Type
        10.2.1 Southeast Asia Measles Vaccine Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Measles Vaccine Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Measles Vaccine Sales Breakdown by Application
        10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Measles Vaccine Market Facts & Figures
    11.1 India Measles Vaccine Sales by Company
        11.1.1 India Measles Vaccine Sales by Company (2016-2021)
        11.1.2 India Measles Vaccine Revenue by Company (2016-2021)
    11.2 India Measles Vaccine Sales Breakdown by Type
        11.2.1 India Measles Vaccine Sales Breakdown by Type (2016-2021)
        11.2.2 India Measles Vaccine Sales Breakdown by Type (2022-2027)
    11.3 India Measles Vaccine Sales Breakdown by Application
        11.3.1 India Measles Vaccine Sales Breakdown by Application (2016-2021)
        11.3.2 India Measles Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Measles Vaccine Business
    12.1 GSK
        12.1.1 GSK Corporation Information
        12.1.2 GSK Business Overview
        12.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 GSK Measles Vaccine Products Offered
        12.1.5 GSK Recent Development
    12.2 Sanofi-Pasteur
        12.2.1 Sanofi-Pasteur Corporation Information
        12.2.2 Sanofi-Pasteur Business Overview
        12.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
        12.2.5 Sanofi-Pasteur Recent Development
    12.3 Merck
        12.3.1 Merck Corporation Information
        12.3.2 Merck Business Overview
        12.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Merck Measles Vaccine Products Offered
        12.3.5 Merck Recent Development
    12.4 Novartis
        12.4.1 Novartis Corporation Information
        12.4.2 Novartis Business Overview
        12.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Novartis Measles Vaccine Products Offered
        12.4.5 Novartis Recent Development
    12.5 Pfizer
        12.5.1 Pfizer Corporation Information
        12.5.2 Pfizer Business Overview
        12.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Pfizer Measles Vaccine Products Offered
        12.5.5 Pfizer Recent Development
    12.6 Serum Institute of India
        12.6.1 Serum Institute of India Corporation Information
        12.6.2 Serum Institute of India Business Overview
        12.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Serum Institute of India Measles Vaccine Products Offered
        12.6.5 Serum Institute of India Recent Development
    12.7 China National Biotech Group
        12.7.1 China National Biotech Group Corporation Information
        12.7.2 China National Biotech Group Business Overview
        12.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 China National Biotech Group Measles Vaccine Products Offered
        12.7.5 China National Biotech Group Recent Development
    12.8 Bavarian Nordic
        12.8.1 Bavarian Nordic Corporation Information
        12.8.2 Bavarian Nordic Business Overview
        12.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Bavarian Nordic Measles Vaccine Products Offered
        12.8.5 Bavarian Nordic Recent Development
    12.9 Emergent Biosolutions
        12.9.1 Emergent Biosolutions Corporation Information
        12.9.2 Emergent Biosolutions Business Overview
        12.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Emergent Biosolutions Measles Vaccine Products Offered
        12.9.5 Emergent Biosolutions Recent Development
    12.10 Medimmune
        12.10.1 Medimmune Corporation Information
        12.10.2 Medimmune Business Overview
        12.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Medimmune Measles Vaccine Products Offered
        12.10.5 Medimmune Recent Development
    12.11 Johnson & Johnson
        12.11.1 Johnson & Johnson Corporation Information
        12.11.2 Johnson & Johnson Business Overview
        12.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Johnson & Johnson Measles Vaccine Products Offered
        12.11.5 Johnson & Johnson Recent Development
    12.12 CSL Limited
        12.12.1 CSL Limited Corporation Information
        12.12.2 CSL Limited Business Overview
        12.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 CSL Limited Measles Vaccine Products Offered
        12.12.5 CSL Limited Recent Development

13 Measles Vaccine Manufacturing Cost Analysis
    13.1 Measles Vaccine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Measles Vaccine
    13.4 Measles Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Measles Vaccine Distributors List
    14.3 Measles Vaccine Customers

15 Market Dynamics
    15.1 Measles Vaccine Market Trends
    15.2 Measles Vaccine Drivers
    15.3 Measles Vaccine Market Challenges
    15.4 Measles Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer

List of Tables Table 1. Global Measles Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Measles Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Measles Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Measles Vaccine Sales (K MT) by Region (2016-2021) Table 5. Global Measles Vaccine Sales Market Share by Region (2016-2021) Table 6. Global Measles Vaccine Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Measles Vaccine Revenue Share by Region (2016-2021) Table 8. Global Measles Vaccine Sales (K MT) Forecast by Region (2022-2027) Table 9. Global Measles Vaccine Sales Market Share Forecast by Region (2022-2027) Table 10. Global Measles Vaccine Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Measles Vaccine Revenue Share Forecast by Region (2022-2027) Table 12. Global Measles Vaccine Sales (K MT) of Key Companies (2016-2021) Table 13. Global Measles Vaccine Sales Share by Company (2016-2021) Table 14. Global Measles Vaccine Revenue (US$ Million) by Company (2016-2021) Table 15. Global Measles Vaccine Revenue Share by Company (2016-2021) Table 16. Global Measles Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles Vaccine as of 2020) Table 17. Global Measles Vaccine Average Price (USD/MT) of Key Company (2016-2021) Table 18. Manufacturers Measles Vaccine Manufacturing Sites and Area Served Table 19. Manufacturers Measles Vaccine Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Measles Vaccine Sales (K MT) by Type (2016-2021) Table 22. Global Measles Vaccine Sales Share by Type (2016-2021) Table 23. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Measles Vaccine Price (USD/MT) by Type (2016-2021) Table 25. Global Measles Vaccine Sales Share by Type (2022-2027) Table 26. Global Measles Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Measles Vaccine Revenue Share by Type (2022-2027) Table 28. Global Measles Vaccine Price (USD/MT) by Type (2022-2027) Table 29. Global Measles Vaccine Sales (K MT) by Application (2016-2021) Table 30. Global Measles Vaccine Sales Share by Application (2016-2021) Table 31. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Measles Vaccine Price (USD/MT) by Application (2016-2021) Table 33. Global Measles Vaccine Sales (K MT) by Application (2022-2027) Table 34. Global Measles Vaccine Sales Share by Application (2022-2027) Table 35. Global Measles Vaccine Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Measles Vaccine Revenue Share by Application (2022-2027) Table 37. Global Measles Vaccine Price (USD/MT) by Application (2022-2027) Table 38. North America Measles Vaccine Sales (K MT) by Company (2016-2021) Table 39. North America Measles Vaccine Sales Market Share by Company (2016-2021) Table 40. North America Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Measles Vaccine Revenue Market Share by Company (2016-2021) Table 42. North America Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 43. North America Measles Vaccine Sales Market Share by Type (2016-2021) Table 44. North America Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 45. North America Measles Vaccine Sales Market Share by Type (2022-2027) Table 46. North America Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 47. North America Measles Vaccine Sales Market Share by Application (2016-2021) Table 48. North America Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 49. North America Measles Vaccine Sales Market Share by Application (2022-2027) Table 50. Europe Measles Vaccine Sales (K MT) by Company (2016-2021) Table 51. Europe Measles Vaccine Sales Market Share by Company (2016-2021) Table 52. Europe Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Measles Vaccine Revenue Market Share by Company (2016-2021) Table 54. Europe Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 55. Europe Measles Vaccine Sales Market Share by Type (2016-2021) Table 56. Europe Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 57. Europe Measles Vaccine Sales Market Share by Type (2022-2027) Table 58. Europe Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 59. Europe Measles Vaccine Sales Market Share by Application (2016-2021) Table 60. Europe Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 61. Europe Measles Vaccine Sales Market Share by Application (2022-2027) Table 62. China Measles Vaccine Sales (K MT) by Company (2016-2021) Table 63. China Measles Vaccine Sales Market Share by Company (2016-2021) Table 64. China Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 65. China Measles Vaccine Revenue Market Share by Company (2016-2021) Table 66. China Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 67. China Measles Vaccine Sales Market Share by Type (2016-2021) Table 68. China Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 69. China Measles Vaccine Sales Market Share by Type (2022-2027) Table 70. China Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 71. China Measles Vaccine Sales Market Share by Application (2016-2021) Table 72. China Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 73. China Measles Vaccine Sales Market Share by Application (2022-2027) Table 74. Japan Measles Vaccine Sales (K MT) by Company (2016-2021) Table 75. Japan Measles Vaccine Sales Market Share by Company (2016-2021) Table 76. Japan Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Measles Vaccine Revenue Market Share by Company (2016-2021) Table 78. Japan Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 79. Japan Measles Vaccine Sales Market Share by Type (2016-2021) Table 80. Japan Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 81. Japan Measles Vaccine Sales Market Share by Type (2022-2027) Table 82. Japan Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 83. Japan Measles Vaccine Sales Market Share by Application (2016-2021) Table 84. Japan Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 85. Japan Measles Vaccine Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Measles Vaccine Sales (K MT) by Company (2016-2021) Table 87. Southeast Asia Measles Vaccine Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Measles Vaccine Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 91. Southeast Asia Measles Vaccine Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 93. Southeast Asia Measles Vaccine Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 95. Southeast Asia Measles Vaccine Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 97. Southeast Asia Measles Vaccine Sales Market Share by Application (2022-2027) Table 98. India Measles Vaccine Sales (K MT) by Company (2016-2021) Table 99. India Measles Vaccine Sales Market Share by Company (2016-2021) Table 100. India Measles Vaccine Revenue by Company (2016-2021) & (US$ Million) Table 101. India Measles Vaccine Revenue Market Share by Company (2016-2021) Table 102. India Measles Vaccine Sales by Type (2016-2021) & (K MT) Table 103. India Measles Vaccine Sales Market Share by Type (2016-2021) Table 104. India Measles Vaccine Sales by Type (2022-2027) & (K MT) Table 105. India Measles Vaccine Sales Market Share by Type (2022-2027) Table 106. India Measles Vaccine Sales by Application (2016-2021) & (K MT) Table 107. India Measles Vaccine Sales Market Share by Application (2016-2021) Table 108. India Measles Vaccine Sales by Application (2022-2027) & (K MT) Table 109. India Measles Vaccine Sales Market Share by Application (2022-2027) Table 110. GSK Corporation Information Table 111. GSK Description and Business Overview Table 112. GSK Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 113. GSK Measles Vaccine Product Table 114. GSK Recent Development Table 115. Sanofi-Pasteur Corporation Information Table 116. Sanofi-Pasteur Description and Business Overview Table 117. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 118. Sanofi-Pasteur Measles Vaccine Product Table 119. Sanofi-Pasteur Recent Development Table 120. Merck Corporation Information Table 121. Merck Description and Business Overview Table 122. Merck Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 123. Merck Measles Vaccine Product Table 124. Merck Recent Development Table 125. Novartis Corporation Information Table 126. Novartis Description and Business Overview Table 127. Novartis Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 128. Novartis Measles Vaccine Product Table 129. Novartis Recent Development Table 130. Pfizer Corporation Information Table 131. Pfizer Description and Business Overview Table 132. Pfizer Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 133. Pfizer Measles Vaccine Product Table 134. Pfizer Recent Development Table 135. Serum Institute of India Corporation Information Table 136. Serum Institute of India Description and Business Overview Table 137. Serum Institute of India Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 138. Serum Institute of India Measles Vaccine Product Table 139. Serum Institute of India Recent Development Table 140. China National Biotech Group Corporation Information Table 141. China National Biotech Group Description and Business Overview Table 142. China National Biotech Group Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 143. China National Biotech Group Measles Vaccine Product Table 144. China National Biotech Group Recent Development Table 145. Bavarian Nordic Corporation Information Table 146. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 147. Bavarian Nordic Description and Business Overview Table 148. Bavarian Nordic Measles Vaccine Product Table 149. Bavarian Nordic Recent Development Table 150. Emergent Biosolutions Corporation Information Table 151. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 152. Emergent Biosolutions Description and Business Overview Table 153. Emergent Biosolutions Measles Vaccine Product Table 154. Emergent Biosolutions Recent Development Table 155. Medimmune Corporation Information Table 156. Medimmune Description and Business Overview Table 157. Medimmune Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 158. Medimmune Measles Vaccine Product Table 159. Medimmune Recent Development Table 160. Johnson & Johnson Corporation Information Table 161. Johnson & Johnson Description and Business Overview Table 162. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 163. Johnson & Johnson Measles Vaccine Product Table 164. Johnson & Johnson Recent Development Table 165. CSL Limited Corporation Information Table 166. CSL Limited Description and Business Overview Table 167. CSL Limited Measles Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021) Table 168. CSL Limited Measles Vaccine Product Table 169. CSL Limited Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Measles Vaccine Distributors List Table 173. Measles Vaccine Customers List Table 174. Measles Vaccine Market Trends Table 175. Measles Vaccine Market Drivers Table 176. Measles Vaccine Market Challenges Table 177. Measles Vaccine Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Measles Vaccine Product Picture Figure 2. Global Measles Vaccine Sales Market Share by Type in 2021 & 2027 Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture Figure 5. Global Measles Vaccine Sales Market Share by Application in 2021 & 2027 Figure 6. Children Examples Figure 7. Adults Examples Figure 8. Global Measles Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Measles Vaccine Sales Growth Rate (2016-2027) & (US$ Million) Figure 10. Global Measles Vaccine Sales (K MT) Growth Rate (2016-2027) Figure 11. Global Measles Vaccine Price Trends Growth Rate (2016-2027) (USD/MT) Figure 12. Global Measles Vaccine Revenue Market Share by Region: 2016 VS 2021 Figure 13. Global Measles Vaccine Revenue Market Share by Region: 2021 VS 2027 Figure 14. North America Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 15. North America Measles Vaccine Sales (K MT) Growth Rate (2016-2027) Figure 16. Europe Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 17. Europe Measles Vaccine Sales (Million USD) Growth Rate (2016-2027) Figure 18. China Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 19. China Measles Vaccine Sales (Million USD) and Growth Rate (2016-2027) Figure 20. Japan Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Japan Measles Vaccine Sales (Million USD) Growth Rate (2016-2027) Figure 22. Southeast Asia Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Measles Vaccine Sales (Million USD) Growth Rate (2016-2027) Figure 24. India Measles Vaccine Revenue (Million USD) Growth Rate (2016-2027) Figure 25. India Measles Vaccine Sales (Million USD) Growth Rate (2016-2027) Figure 26. Global 5 Largest Measles Vaccine Players Market Share by Revenue in Measles Vaccine: 2016 & 2020 Figure 27. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 28. Global Measles Vaccine Revenue Share by Type (2016-2021) Figure 29. Global Measles Vaccine Revenue Growth Rate by Type in 2016 & 2020 Figure 30. Global Measles Vaccine Revenue Share by Application (2016-2021) Figure 31. Global Measles Vaccine Revenue Growth Rate by Application in 2016 & 2020 Figure 32. North America Measles Vaccine Sales Market Share by Type in 2020 Figure 33. North America Measles Vaccine Sales Market Share by Application in 2020 Figure 34. Europe Measles Vaccine Sales Market Share by Type in 2020 Figure 35. Europe Measles Vaccine Sales Market Share by Application in 2020 Figure 36. China Measles Vaccine Sales Market Share by Type in 2020 Figure 37. China Measles Vaccine Sales Market Share by Application in 2020 Figure 38. Japan Measles Vaccine Sales Market Share by Type in 2020 Figure 39. Japan Measles Vaccine Sales Market Share by Application in 2020 Figure 40. Southeast Asia Measles Vaccine Sales Market Share by Type in 2020 Figure 41. Southeast Asia Measles Vaccine Sales Market Share by Application in 2020 Figure 42. India Measles Vaccine Sales Market Share by Type in 2020 Figure 43. India Measles Vaccine Sales Market Share by Application in 2020 Figure 44. Key Raw Materials Price Trend Figure 45. Manufacturing Cost Structure of Measles Vaccine Figure 46. Manufacturing Process Analysis of Measles Vaccine Figure 47. Measles Vaccine Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us